Business News

Avience Biomedicals shares make blockbuster debut, list at 90% premium on NSE SME

FinSiddhi

Avience Biomedicals made a spectacular debut on the NSE SME platform, with its shares rocketing 90% on listing day. The Rs 30.24 crore IPO, which was oversubscribed a staggering 385 times, saw strong demand across all investor categories. The company, a manufacturer of molecular diagnostic solutions, plans to use the IPO proceeds to expand its manufacturing capabilities and meet working capital needs.

Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.

Read more at the source

Related Posts

In 2008, researchers stripped snow from New Hampshire forest plots for 2 winters; soil frost deepened 39.5 cm and nitrogen leaching reached 2.8 kg per hectare

In New Hampshire’s White Mountains, the removal of snow cover led to increased soil frost, causing root damage to trees. This impairment limited their nutrient absorption and resulted in nitrogen draining into streams and groundwater. Over two winters, researchers observed these nitrogen losses, identifying root damage as a crucial factor behind the ecosystem disruption.

Gold, silver prices may rise next week as US inflation data, Gulf tensions guide markets

Gold and silver prices are expected to remain firm next week. Investors will track inflation data from major economies and West Asia developments. Upcoming Chinese economic data will also be important for industrial metals. Analysts predict gold and silver will trade with a positive bias. Volatility is expected to remain elevated due to economic data…

Leave a Reply

Your email address will not be published. Required fields are marked *